Prognosis After Withdrawal of Cardioprotective Therapy in Patients With Improved Cancer Therapeutics–Related Cardiac Dysfunction
Patients who withdrew CPT after demonstrating improvement in CTRCD experienced worse clinical outcomes. Notably, a significant decrease in LVEF was observed after CPT withdrawal in patients with a baseline LVEF <45%.
Authors
- Hyun Yoon (ORCID: https://orcid.org/0000-0002-4741-9664)
- Kye Hun Kim (ORCID: https://orcid.org/0000-0002-6885-1501)
- Ga Hui Choi (ORCID: https://orcid.org/0000-0002-3672-8402)
- Sang‐Geon Cho (ORCID: https://orcid.org/0000-0002-1373-1887)
- Jae Yeong Cho (ORCID: https://orcid.org/0000-0002-9393-2821)
- Hyukjin Park (ORCID: https://orcid.org/0000-0001-6832-9716)
- Nuri Lee
- Cho Hee Hwang
- Youngkeun Ahn
Institutions
- Chonnam National University (KR)
- Chonnam National University Hospital (KR)
- Chonnam National University Hwasun Hospital (KR)
Publication Details
- Journal
- JACC CardioOncology
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1016/j.jaccao.2024.07.018
- Citations
- 8
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 3.22